1. Maybe true, but there is also the interesting fact that pharma wanted and got immunity, so it is in pharma's interest to prevent the full authorization;

2. You missed the fact that risks depend on personal data, factors, weights of those factors. Also, cheap treatments are available and effective which push the risk of bad COVID to such small number it's immaterial to most anti-covidism people (a political stance).